Dea Slade

12PUBLICATIONS
24CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Polymerisation mechanismsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 14, 2026
PARP7 inhibition and a STING agonist potentiate radiation-induced immunogenicity in glioblastoma.

Luca Lippert, Ava Kleinwächter, Anna Ohradanova-Repic

|Jul 21, 2025
Molecular features of TNBC govern heterogeneity in the response to radiation and autophagy inhibition.

Patrick Fischer, Maximilian Schmid, Anna Ohradanova-Repic

|Mar 25, 2025
PARP7 as a new target for activating anti-tumor immunity in cancer.

Katerina Popova, Johannes Benedum, Magdalena Engl

|Nov 30, 2023
The SPOC proteins DIDO3 and PHF3 co-regulate gene expression and neuronal differentiation.

Johannes Benedum, Vedran Franke, Lisa-Marie Appel

|Mar 17, 2023
Leveraging homologous recombination repair deficiency in sarcoma.

Dea Slade, Joanna I Loizou

Pageof 2